Skip to main content
TipRanks
Go Ultimate75% OFF

Raymond John Spencer Insider Profile

4 Followers

Raymond John Spencer, former Interim Chief Financial Officer (part-time) at Summit Therapeutics, holds 1.20M shares in Summit Therapeutics (Ticker: GB:SUMM). Most recently, Raymond John Spencer Bought 400,000 shares of Summit Therapeutics on Aug 04, 2010 for an estimated value of 11.72K .

Raymond John Spencer's Trading History

SUMM
Summit Therapeutics
Aug 04, 2010―Informative Buy11.72K£450.00K
GB:SUMM
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 04, 2010Informative Buy£11.72K400,000£3.00――
Nov 02, 2009Informative Buy£11.50K200,000£6.00――
Oct 28, 2009Informative Buy£5.50K100,000£6.00――

You May Also Like

Raymond John Spencer insider profile FAQ

What is the percentage of profitable transactions made by Raymond John Spencer?
The percentage of profitable transactions made by Raymond John Spencer is 33%.
What is the average return per transaction made by Raymond John Spencer?
The average return per transaction made by Raymond John Spencer is 9.30%.
What stocks does Raymond John Spencer hold?
Raymond John Spencer holds: GB:SUMM stocks.
What was Raymond John Spencer’s latest transaction?
Raymond John Spencer’s latest transaction was an Informative Buy of 11.72K .
What is Raymond John Spencer's role in Summit Therapeutics?
Raymond John Spencer's role in Summit Therapeutics is Interim Chief Financial Officer (part-time).
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.